Global shares rise on hopes for US stimulus package

Monday, March 1, 2021 | Yuri Kageyama, AP Business Writer

People walk by an electronic stock board of a securities firm in Tokyo, Monday, March 1, 2021. Asian shares were higher on Monday on hopes for President Joe Biden’s stimulus package and bargain-hunting buying after the shares’ fall last week. (AP Photo/Koji Sasahara)

TOKYO (AP) — Global shares rose Monday, lifted by hopes President Joe Biden's stimulus package will be enacted and by bargain-hunting after sell offs last week.

France's CAC 40 added 1.5% in early trading to 5,788.93, while Germany's DAX edged up 1.3% to 13,964.06. Britain's FTSE 100 jumped 1.6% to 6,590.00. U.S. shares were set for gains. with the future for the Dow industrials at 31,249.50, up 1.1%. The S&P 500 future was up 1.2% at 3,854.38.

Japan's benchmark Nikkei 225 surged 2.4% to finish at 29,663.50. Australia's S&P/ASX 200 jumped 1.7% to 6,789.60.

Hong Kong's Hang Seng advanced 1.6% to 29,452.57, while the Shanghai Composite rose 1.2% to 3,551.40, despite a survey showing slightly weaker manufacturing indicators for the month of February.

South Korean markets were closed for a national holiday. But the government reported that exports rose 9.5% in February from a year earlier and imports jumped nearly 14%, in signs the economy is picking up momentum.

A manufacturing survey for Japan showed an expansion in February for the first time since April 2019. The au Jibun purchasing managers index reading of 51.4 — on a scale of 1-100, where 50 and above show expansion — was a sharp improvement from the 49.8 level registered in January.

The survey showed improvements in many areas including higher sales and orders and higher exports, reflecting improved demand in overseas markets, especially China.

Asia's export-reliant economies are counting on a healthy American economy to boost trade, which has tended to stagnate during the pandemic. As the region's recovery begins to take off, vaccine rollouts are also gradually getting started in most Asian nations.

Worries about the economy, as well as about COVID-19, are still relatively widespread in Japan, which is seeing yet another wave of coronavirus cases. Some urban areas, like Osaka, have lifted measures to help prevent the spread of infections, but the Tokyo area remains under a “state of emergency,” focused on having restaurants, bars and other businesses close at 8 p.m. Japan has never had a lockdown.

The U.S. House of Representatives approved Biden’s $1.9 trillion pandemic relief bill on Friday and it now goes to the Senate for approval. The bill infuses cash across the struggling economy to individuals, businesses, schools, states and cities battered by COVID-19.

The U.S. stimulus bill would include yet another round of one-time payments to most Americans, including an expansion of other refundable tax credits like the child tax credit, and additional aid to state and local governments to combat the pandemic.

“It is still fundamentally good news that the sell-offs' economic underpinnings — increasing mobility, inflation, and US stimulus — are still intact, with global vaccinations rolling out faster than expected,” said Stephen Innes, chief global market strategist at Axi.

In energy trading, benchmark U.S. crude gained $1.12 to $62.62 a barrel in electronic trading on the New York Mercantile Exchange. It lost $2.03 on Friday to $61.50 per barrel. Brent crude, the international standard, rose $1.18 to $65.60 a barrel.

In currency trading, the U.S. dollar inched up to 106.62 Japanese yen from 106.56 yen. The euro cost $1.2068, down from $1.2074.


Yuri Kageyama is on Twitter

7 Marijuana Stocks Worth Speculating On

To say it’s been a rough two years for the cannabis industry is an understatement. Due to a combination of issues (including some self-inflicted wounds), the cannabis boom predicted in 2018 has not materialized. But that could be about to change.

If Joe Biden wins the presidential election, it will likely be part of a “Blue Wave” that will bring Democratic party control of both houses of Congress. And even if President Trump successfully wins a second term, it is still possible that Republicans could lose their hold on the Senate.

The bottom line is there is a range of outcomes that are possible. Most of those outcomes are favorable to the legalization of marijuana. And even if cannabis is not made legal on the federal level, it seems likely that the remaining states holding out will take steps to legalization. That’s because, like gambling, cannabis may create an economic lift that cash-strapped states may find too difficult to turn down.

One thing is certain. If you wait until the right time, you’ll have missed out on some eye-popping initial gains. But to get that reward in the future, you’ll need to assume some risk now. In this special presentation, we’ve identified seven cannabis stocks that you can consider when evaluating your opportunity in the cannabis sector.

View the "7 Marijuana Stocks Worth Speculating On ".

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.